Early research (Phase 1)Study completedNCT04810598
What this trial is testing
Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function
Who this might be right for
Renal ImpairmentRenal Disease
AbbVie 12